These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 17433904)

  • 41. Evaluation of the procoagulant activity in the plasma of cancer patients using a thrombin generation assay.
    Debaugnies F; Azerad MA; Noubouossié D; Rozen L; Hemker HC; Corazza F; Efira A; Demulder A
    Thromb Res; 2010 Dec; 126(6):531-5. PubMed ID: 20870277
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral contraception and thrombophilia.
    Blickstein D; Blickstein I
    Curr Opin Obstet Gynecol; 2007 Aug; 19(4):370-6. PubMed ID: 17625421
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation and performance characteristics of the automated coagulation analyzer ACL TOP.
    Appert-Flory A; Fischer F; Jambou D; Toulon P
    Thromb Res; 2007; 120(5):733-43. PubMed ID: 17275069
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization and classification of external quality assessment schemes (EQA) according to objectives such as evaluation of method and participant bias and standard deviation. External Quality Assessment (EQA) Working Group A on Analytical Goals in Laboratory Medicine.
    Libeer JC; Baadenhuijsen H; Fraser CG; Petersen PH; Ricós C; Stöckl D; Thienpont L
    Eur J Clin Chem Clin Biochem; 1996 Aug; 34(8):665-78. PubMed ID: 8877346
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
    Gessoni G; Valverde S
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A review of the clinical and diagnostic utility of laboratory tests for the detection of congenital thrombophilia.
    Tripodi A
    Semin Thromb Hemost; 2005 Feb; 31(1):25-32. PubMed ID: 15706472
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quality control and quality assessment of coagulation tests in Japan.
    Matsuno K; Yasushi T
    Southeast Asian J Trop Med Public Health; 2002; 33 Suppl 2():99-103. PubMed ID: 12755278
    [TBL] [Abstract][Full Text] [Related]  

  • 48. External quality assessment scheme for hemostasis in India.
    Mammen J; Nair SC; Srivastava A
    Semin Thromb Hemost; 2007 Apr; 33(3):265-72. PubMed ID: 17427061
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence and type of pre-analytical problems for inpatients samples in coagulation laboratory.
    Salvagno GL; Lippi G; Bassi A; Poli G; Guidi GC
    J Eval Clin Pract; 2008 Apr; 14(2):351-3. PubMed ID: 18324942
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Inherited thrombophilia].
    De Stefano V
    G Ital Nefrol; 2009; 26 Suppl 46():14-9. PubMed ID: 19644814
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of serum angiotensin-converting enzyme.
    Muller BR
    Ann Clin Biochem; 2002 Sep; 39(Pt 5):436-43. PubMed ID: 12227849
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hematologic effects of thrombophilia.
    Fritsma GA; Southern DK
    Clin Lab Sci; 1998; 11(4):233-8. PubMed ID: 10182112
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quality of clinical information: a new approach of EQA in Emilia-Romagna, Italy.
    Baraghini GF; Bolelli GF; Capelli M; Motta R; Andreotti A; Cavicchi S; Castellucci C; Castrioto T; De Santis MC; Franceschetti F
    Ann Ist Super Sanita; 1995; 31(1):197-209. PubMed ID: 8546369
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Laboratory performance in the World Federation of Hemophilia EQA programme, 2003-2008.
    Jennings I; Kitchen DP; Woods TA; Kitchen S; Walker ID; Preston FE
    Haemophilia; 2009 Mar; 15(2):571-7. PubMed ID: 19175423
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular diagnostics in hemostatic disorders.
    Perrotta PL; Svensson AM
    Clin Lab Med; 2009 Jun; 29(2):367-90. PubMed ID: 19665683
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Laboratory testing issues for protein C, protein S, and antithrombin.
    Marlar RA; Gausman JN
    Int J Lab Hematol; 2014 Jun; 36(3):289-95. PubMed ID: 24750675
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of high-risk thrombophilia with an automated, global test: the Coagulation Inhibitor Potential assay.
    Réger B; Losonczy H; Nagy Á; Péterfalvi Á; Mózes R; Pótó L; Farkas N; Kovács GL; Miseta A; Hussain A; Tóth O
    Blood Coagul Fibrinolysis; 2018 Jul; 29(5):435-441. PubMed ID: 29782332
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of coagulation and fibrinolysis in families with unexplained thrombophilia.
    Wichers IM; Tanck MW; Meijers JC; Lisman T; Reitsma PH; Rosendaal FR; Büller HR; Middeldorp S
    Thromb Haemost; 2009 Mar; 101(3):465-70. PubMed ID: 19277406
    [TBL] [Abstract][Full Text] [Related]  

  • 59. External quality assessment schemes in coagulation in Germany: between regulatory bodies and patient outcome.
    Spannagl M; Dick A; Reinauer H
    Semin Thromb Hemost; 2007 Apr; 33(3):259-64. PubMed ID: 17427060
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A multi-laboratory assessment of congenital thrombophilia assays performed on the ACL TOP 50 family for harmonisation of thrombophilia testing in a large laboratory network.
    Favaloro EJ; Mohammed S; Vong R; Chapman K; Swanepoel P; Kershaw G; Cai N; Just S; Connelly L; Brighton T; Pasalic L
    Clin Chem Lab Med; 2021 Sep; 59(10):1709-1718. PubMed ID: 34116591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.